Caeptis 治疗学公司宣布从12月31日起实行20种逆向股分法。 Caeptis Therapeutics announces a 1-for-20 reverse stock split, effective December 31st.

Caeptis治疗学(NASDAQ:CEP)将于12月31日执行12月27日宣布的1对1的20反向股票分割。 Caeptis Therapeutics (NASDAQ: COEP) will execute a 1-for-20 reverse stock split on December 31st, announced on December 27th. 股票调整将在12月30日市场关闭后进行。 Share adjustments will occur after the market closes on December 30th. 该公司专注于癌细胞治疗,开发多发性骨髓瘤,慢性淋巴细胞白血病和急性骨髓性白血病的治疗方法. The company, focusing on cancer cell therapy, develops treatments for multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia.